DS
AZN icon

DRW Securities’s AstraZeneca AZN Stock Holding History

DRW Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,742
Closed -$4.96M – 1287
2025
Q4 		$4.73M Sell
25,742
-6,065
-19% -$1.06M 0.13% 123
2025
Q3 		$4.89M Buy
31,807
+17,543
+123% +$2.66M 0.09% 127
2025
Q2 		$1.99M Buy
14,264
+6,658
+88% +$933K 0.05% 212
2025
Q1 		$1.12M Buy
7,606
+4,999
+192% +$723K 0.03% 249
2024
Q4 		$342K Sell
2,607
-16,127
-86% -$2.26M 0.01% 403
2024
Q3 		$2.92M Buy
18,734
+6,229
+50% +$1.01M 0.08% 123
2024
Q2 		$1.95M Buy
+12,505
New +$1.88M 0.08% 160
2024
Q1 		– Sell
-8,797
Closed -$1.18M – 382
2023
Q4 		$1.18M Buy
8,797
+3,872
+79% +$503K 0.02% 131
2023
Q3 		$667K Sell
4,925
-82,266
-94% -$11.2M 0.01% 187
2023
Q2 		$12.5M Buy
87,191
+16,212
+23% +$2.39M 0.31% 38
2023
Q1 		$9.85M Buy
70,979
+17,931
+34% +$2.41M 0.16% 53
2022
Q4 		$7.19M Buy
53,048
+50,028
+1,657% +$6.27M 0.19% 45
2022
Q3 		$331K Sell
3,020
-670
-18% -$85K 0.01% 176
2022
Q2 		$488K Sell
3,690
-9,308
-72% -$1.22M 0.01% 153
2022
Q1 		$1.73M Sell
12,998
-2,292
-15% -$275K 0.05% 102
2021
Q4 		$1.78M Sell
15,290
-1,412
-8% -$166K 0.05% 74
2021
Q3 		$2.01M Buy
16,702
+533
+3% +$62K 0.09% 77
2021
Q2 		$1.94M Hold
16,169
– – 0.06% 87
2021
Q1 		$1.61M Buy
16,169
+8,936
+124% +$898K 0.06% 67
2020
Q4 		$723K Sell
7,233
-8,206
-53% -$869K 0.03% 81
2020
Q3 		$1.69M Buy
+15,439
New +$1.72M 0.09% 58
2019
Q4 		– Sell
-10,621
Closed -$947K – 228
2019
Q3 		$947K Buy
+10,621
New +$921K 0.06% 81

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $148B AUM

DRW Securities's AZN Position: Q1 2026 in Review

DRW Securities sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 25,742 shares — an estimated $4.96M sold.

DRW Securities first reported a position in AZN in Q3 2019 and held it in 22 quarters. The position peaked at $12.5M in Q2 2023. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • DRW Securities reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 25,742 AstraZeneca shares in Q1 2026, an estimated $4.96M.
  • DRW Securities first reported a position in AstraZeneca in Q3 2019 and held it in 22 quarters.
  • DRW Securities's AstraZeneca position peaked at $12.5M in Q2 2023.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.